BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 25487351)

  • 1. Osteoblast-specific expression of the fibrous dysplasia (FD)-causing mutation Gsα(R201C) produces a high bone mass phenotype but does not reproduce FD in the mouse.
    Remoli C; Michienzi S; Sacchetti B; Consiglio AD; Cersosimo S; Spica E; Robey PG; Holmbeck K; Cumano A; Boyde A; Davis G; Saggio I; Riminucci M; Bianco P
    J Bone Miner Res; 2015 Jun; 30(6):1030-43. PubMed ID: 25487351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Constitutive expression of Gsα(R201C) in mice produces a heritable, direct replica of human fibrous dysplasia bone pathology and demonstrates its natural history.
    Saggio I; Remoli C; Spica E; Cersosimo S; Sacchetti B; Robey PG; Holmbeck K; Cumano A; Boyde A; Bianco P; Riminucci M
    J Bone Miner Res; 2014 Nov; 29(11):2357-68. PubMed ID: 24764158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in gene expression in human skeletal stem cells transduced with constitutively active Gsα correlates with hallmark histopathological changes seen in fibrous dysplastic bone.
    Raimondo D; Remoli C; Astrologo L; Burla R; La Torre M; Vernì F; Tagliafico E; Corsi A; Del Giudice S; Persichetti A; Giannicola G; Robey PG; Riminucci M; Saggio I
    PLoS One; 2020; 15(1):e0227279. PubMed ID: 31999703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of an active Gα
    Zhao X; Deng P; Iglesias-Bartolome R; Amornphimoltham P; Steffen DJ; Jin Y; Molinolo AA; de Castro LF; Ovejero D; Yuan Q; Chen Q; Han X; Bai D; Taylor SS; Yang Y; Collins MT; Gutkind JS
    Proc Natl Acad Sci U S A; 2018 Jan; 115(3):E428-E437. PubMed ID: 29282319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induced
    Khan SK; Yadav PS; Elliott G; Hu DZ; Xu R; Yang Y
    Proc Natl Acad Sci U S A; 2018 Jan; 115(3):E418-E427. PubMed ID: 29158412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gsalpha gene mutations in monostotic fibrous dysplasia of bone and fibrous dysplasia-like low-grade central osteosarcoma.
    Pollandt K; Engels C; Kaiser E; Werner M; Delling G
    Virchows Arch; 2001 Aug; 439(2):170-5. PubMed ID: 11561757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RANKL Inhibition in Fibrous Dysplasia of Bone: A Preclinical Study in a Mouse Model of the Human Disease.
    Palmisano B; Spica E; Remoli C; Labella R; Di Filippo A; Donsante S; Bini F; Raimondo D; Marinozzi F; Boyde A; Robey P; Corsi A; Riminucci M
    J Bone Miner Res; 2019 Dec; 34(12):2171-2182. PubMed ID: 31295366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GNAS transcripts in skeletal progenitors: evidence for random asymmetric allelic expression of Gs alpha.
    Michienzi S; Cherman N; Holmbeck K; Funari A; Collins MT; Bianco P; Robey PG; Riminucci M
    Hum Mol Genet; 2007 Aug; 16(16):1921-30. PubMed ID: 17566083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potent constitutive cyclic AMP-generating activity of XLαs implicates this imprinted GNAS product in the pathogenesis of McCune-Albright syndrome and fibrous dysplasia of bone.
    Mariot V; Wu JY; Aydin C; Mantovani G; Mahon MJ; Linglart A; Bastepe M
    Bone; 2011 Feb; 48(2):312-20. PubMed ID: 20887824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucocorticoids decrease interleukin-6 levels and induce mineralization of cultured osteogenic cells from children with fibrous dysplasia.
    Stanton RP; Hobson GM; Montgomery BE; Moses PA; Smith-Kirwin SM; Funanage VL
    J Bone Miner Res; 1999 Jul; 14(7):1104-14. PubMed ID: 10404010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibrous Dysplasia/McCune-Albright Syndrome: Clinical and Translational Perspectives.
    Robinson C; Collins MT; Boyce AM
    Curr Osteoporos Rep; 2016 Oct; 14(5):178-86. PubMed ID: 27492469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A sensitive mutation-specific screening technique for GNAS1 mutations in cases of fibrous dysplasia: the first report of a codon 227 mutation in bone.
    Idowu BD; Al-Adnani M; O'Donnell P; Yu L; Odell E; Diss T; Gale RE; Flanagan AM
    Histopathology; 2007 May; 50(6):691-704. PubMed ID: 17493233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different roles of GNAS and cAMP signaling during early and late stages of osteogenic differentiation.
    Zhang S; Kaplan FS; Shore EM
    Horm Metab Res; 2012 Sep; 44(10):724-31. PubMed ID: 22903279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Skeletal progenitors and the GNAS gene: fibrous dysplasia of bone read through stem cells.
    Riminucci M; Robey PG; Saggio I; Bianco P
    J Mol Endocrinol; 2010 Dec; 45(6):355-64. PubMed ID: 20841428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A pathogenic role for brain-derived neurotrophic factor (BDNF) in fibrous dysplasia of bone.
    Palmisano B; Farinacci G; Campolo F; Tavanti C; Stefano A; Donsante S; Ippolito E; Giannicola G; Venneri MA; Corsi A; Riminucci M
    Bone; 2024 Apr; 181():117047. PubMed ID: 38331308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The CREB-Smad6-Runx2 axis contributes to the impaired osteogenesis potential of bone marrow stromal cells in fibrous dysplasia of bone.
    Fan QM; Yue B; Bian ZY; Xu WT; Tu B; Dai KR; Li G; Tang TT
    J Pathol; 2012 Sep; 228(1):45-55. PubMed ID: 22450860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and regulation of amphiregulin in Gsα-mutated human bone marrow stromal cells of fibrous dysplasia of mandible.
    Jia S; Yu J; Zhang D; Zheng P; Zhang S; Ma L; Liu G; Li S
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2011 May; 111(5):618-26. PubMed ID: 21439861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activating GNAS mutations in parosteal osteosarcoma.
    Carter JM; Inwards CY; Jin L; Evers B; Wenger DE; Oliveira AM; Fritchie KJ
    Am J Surg Pathol; 2014 Mar; 38(3):402-9. PubMed ID: 24525511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genotype-Phenotype Correlation in Fibrous Dysplasia/McCune-Albright Syndrome.
    Zhadina M; Roszko KL; Geels RES; de Castro LF; Collins MT; Boyce AM
    J Clin Endocrinol Metab; 2021 Apr; 106(5):1482-1490. PubMed ID: 33512531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The activating mutation R201C in GNAS promotes intestinal tumourigenesis in Apc(Min/+) mice through activation of Wnt and ERK1/2 MAPK pathways.
    Wilson CH; McIntyre RE; Arends MJ; Adams DJ
    Oncogene; 2010 Aug; 29(32):4567-75. PubMed ID: 20531296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.